(PharmaNewsWire.Com, July 21, 2021 ) Glycomics is the comprehensive research of the structure of the glycomes, such as genetic, physiologic, pathologic, and other aspects of the given cell or organism. Glycomics study is majorly utilized in various applications like drug discovery, oncology, immunology, and more.
Glycomics market is expanding worldwide, and therefore the factors driving this market are increased study activities on glycomics research, pharmaceutical and biotechnology companies are investing in research and development, and development within the proteomics market. Additionally , developing countries like India and China are providing productive opportunities for vendors during this market.
The Glycomics market is segmented on the basis of product is enzymes, instruments, kits, carbohydrates, and reagents & chemicals. The enzyme segment has acquired the largest share in the glycomics market growth. In the application division, the drug discovery and development is considered to have the largest share in the glycomics market because ofthe increasing investments in research and development. Further, based on end-users, the market has been segregated into academic research institutes, pharmaceutical & biotechnology companies, and clinical laboratories.
Thermo Fisher Scientific, New England Biolabs, Shimadzu Corporation, Merck KGaA, Agilent Technologies, Asparia Glycomics S.L., Bio-Techne, Bruker Corporation, Danaher Corporation, Takara Bio, S-BIO subsidiary of Sumitomo Bakelite Co. Ltd., Waters Corporation, RayBiotech, Z Biotech, Chemily Glycoscience, Dextra Laboratories, Lectenz Bio, and Ludger Ltd., these are the major key players in the global glycomics market.
We are a growth partnership company that provides fact-based consulting services focused on helping our clients achieve incremental and transformational growth competing in business-to- business and business-to- consumer markets. We facilitate their growth journey through an environment that is dominated by accelerating change, constant evolution of new business models, disruptive trends and technologies in their respective industry.
We serve a wide spectrum of global industries such as Semiconductor and Electronics, Information Technology, Communication, Medical Devices, Pharmaceuticals, Defense, Aviation, and Chemicals among others. Our well-seasoned blend of technical and marketing expertise enables us to serve our customers with comprehensive study of global supply chains that helps them to devise highly effective strategies.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
